← Open Payments lookup

VERONICA EMHOLTZ: Open Payments

NPI 1548595937 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$729 in 35 payments from 16 companies in 2025. Trend: 2023 $1,812 · 2024 $808 · 2025 $729

Food & beverage: $729
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$107
Intercept Pharmaceuticals, Inc.4$80
Gilead Sciences, Inc.4$77
Takeda Pharmaceuticals U.S.A., Inc.2$59
Ipsen Biopharmaceuticals, Inc3$59
Novo Nordisk Inc3$59
Mallinckrodt Hospital Products Inc.2$51
ORPHALAN INC2$48
Madrigal Pharmaceuticals2$38
Merck Sharp & Dohme LLC1$34

Products named: XIFAXAN, OCALIVA, LIVTENCITY, IQIRVO, TERLIVAZ, CUVRIOR, REZDIFFRA, Wegovy.

Industry payments across TX — which companies pay providers there.